Discover opportunities months before the RFP drops
Learn more →Key metrics and characteristics
The county where this buyer is located.
Physical address of this buyer.
Postal code for this buyer's location.
How likely this buyer is to spend on new technology based on operating budget trends.
How likely this buyer is to adopt new AI technologies.
How often this buyer champions startups and early adoption.
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Active opportunities open for bidding
National Institutes of Health Niaid
Supply of In Vitro Medical Diagnostic Reagent Kits: Rapid Melioidosis Antibody and Antigen Lateral Flow Assays.
Posted Date
Jul 14, 2026
Due Date
Jul 30, 2026
National Institutes of Health Niaid
Close: Jul 30, 2026
Supply of In Vitro Medical Diagnostic Reagent Kits: Rapid Melioidosis Antibody and Antigen Lateral Flow Assays.
AvailableNational Institutes of Health Niaid
U.S. Embassy Phnom Penh issued RFQ 19CB6026Q0025 seeking laboratory equipment for NIAID/NIH, including a benchtop real-time PCR detection system (96-well format) with optical detection for at least five fluorescent dye channels and a software license. Deliveries are to the National Center for Parasitology, Entomology and Malaria Control in Phnom Penh within 30 days of a purchase order; vendors must offer new, manufacturer-approved items, provide technical specifications and country-of-origin, and note VAT applies. The synopsis was posted July 17, 2026 and proposals are due Aug 4, 2026 (response deadline 05:00 a.m. EDT).
Posted Date
Jul 17, 2026
Due Date
Aug 4, 2026
Release: Jul 17, 2026
National Institutes of Health Niaid
Close: Aug 4, 2026
U.S. Embassy Phnom Penh issued RFQ 19CB6026Q0025 seeking laboratory equipment for NIAID/NIH, including a benchtop real-time PCR detection system (96-well format) with optical detection for at least five fluorescent dye channels and a software license. Deliveries are to the National Center for Parasitology, Entomology and Malaria Control in Phnom Penh within 30 days of a purchase order; vendors must offer new, manufacturer-approved items, provide technical specifications and country-of-origin, and note VAT applies. The synopsis was posted July 17, 2026 and proposals are due Aug 4, 2026 (response deadline 05:00 a.m. EDT).
AvailableNational Institutes of Health Niaid
The National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) is seeking the acquisition of a deep ultraviolet 304 nm laser source for high-dimensional flow cytometry. This DUV 304 nm laser is required to upgrade NIAID's high-dimensional flow cytometers, enabling excitation of deep ultraviolet fluorophores used in advanced immunology research. The acquisition supports research capabilities at NIH facilities in Bethesda, Maryland, with delivery coordinated through the NIH Office of Logistics and Acquisition Operations.
Posted Date
Jul 14, 2026
Due Date
Jul 25, 2026
Release: Jul 14, 2026
National Institutes of Health Niaid
Close: Jul 25, 2026
The National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) is seeking the acquisition of a deep ultraviolet 304 nm laser source for high-dimensional flow cytometry. This DUV 304 nm laser is required to upgrade NIAID's high-dimensional flow cytometers, enabling excitation of deep ultraviolet fluorophores used in advanced immunology research. The acquisition supports research capabilities at NIH facilities in Bethesda, Maryland, with delivery coordinated through the NIH Office of Logistics and Acquisition Operations.
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
Track vendor wins and renewal opportunities
National Institutes of Health Niaid
COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
Effective Date
Sep 1, 2020
Expires
Effective: Sep 1, 2020
National Institutes of Health Niaid
Expires:
COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
AvailableNational Institutes of Health Niaid
TO MAINTAIN AND OPERATE SECURE STATE-OF-THE-ART COMPUTER-BASED SYSTEMS THAT PROVIDE FOR TRACKING, PROCESSING, COORDINATION, AND ANALYSIS OF DATA COLLECTED, GENERATED, AND PROCESSED PRIMARILY BY THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH A
Effective Date
Apr 1, 2021
Expires
Effective: Apr 1, 2021
National Institutes of Health Niaid
Expires:
TO MAINTAIN AND OPERATE SECURE STATE-OF-THE-ART COMPUTER-BASED SYSTEMS THAT PROVIDE FOR TRACKING, PROCESSING, COORDINATION, AND ANALYSIS OF DATA COLLECTED, GENERATED, AND PROCESSED PRIMARILY BY THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH A
AvailableNational Institutes of Health Niaid
IGF::OT::IGF NIAID VIROLOGY QUALITY ASSURANCE (VQA)
Effective Date
Jun 21, 2019
Expires
Effective: Jun 21, 2019
National Institutes of Health Niaid
Expires:
IGF::OT::IGF NIAID VIROLOGY QUALITY ASSURANCE (VQA)
See expiring contracts, renewal risk, pricing history, and competitor awards — then sync the data to your CRM.
Keep your public sector contacts fresh and actionable. No more stale data.
Premium
Win more deals with deep buyer insights
Decision Makers
Director, Occupational Health and Safety, IRF-Frederick
Premium
Access the largest public sector contact database
© 2026 Starbridge